How to Take Qsymia: Dosing, Timing, and Side Effects

Qsymia is taken once a day in the morning, with or without food. The dose starts low and increases gradually over several months, giving your body time to adjust. Here’s what the full process looks like from your first capsule through long-term use.

When and How to Take It

Swallow the capsule whole each morning. You can take it on an empty stomach or with breakfast. The one timing rule that matters: avoid taking it in the evening. Qsymia contains phentermine, a stimulant that suppresses appetite, and taking it later in the day can interfere with sleep.

If you miss a dose, skip it and take your next dose the following morning. Don’t double up.

The Step-Up Dosing Schedule

Qsymia isn’t prescribed at full strength from the start. You move through a gradual increase that takes at least 14 weeks, and potentially longer if your prescriber raises you to the highest dose.

  • First 14 days: 3.75 mg phentermine / 23 mg topiramate. This is the starter dose, designed to let your body adjust to the medication with minimal side effects.
  • Weeks 3 through 14: 7.5 mg / 46 mg. This is the standard maintenance dose, and many people stay here. In clinical trials, patients on this dose lost an average of 8.1 kg (about 18 pounds), or roughly 7.8% of their body weight, over 56 weeks.
  • If weight loss is insufficient after 12 weeks at 7.5/46: Your prescriber may move you to a higher dose. You’ll spend 14 days at 11.25 mg / 69 mg as a transition step.
  • Then 12 more weeks at the top dose: 15 mg / 92 mg. Patients on this dose in the CONQUER trial lost an average of 10.2 kg (about 22.5 pounds), or 9.8% of body weight, at one year.

The decision to increase your dose depends on how much weight you’ve lost at each checkpoint. If you haven’t lost at least 3% of your body weight after 12 weeks on the mid-level dose, your prescriber will discuss whether it makes sense to go higher or stop the medication.

What Happens Before You Start

Before your first prescription, expect bloodwork. Your provider will check kidney function, potassium levels, and bicarbonate (a marker for acid-base balance in your blood). If you have type 2 diabetes, blood sugar levels will also be tested. These aren’t one-time checks. They’ll be repeated periodically while you’re on the medication.

If you can become pregnant, a negative pregnancy test is required before starting Qsymia and then monthly throughout treatment. This isn’t optional. Qsymia carries a serious risk of birth defects, specifically cleft lip and cleft palate, if taken during the first trimester. The medication is only available through certified pharmacies as part of a special FDA safety program, and you’ll receive written materials about this risk with every fill.

Side Effects to Watch For

The most common early side effects are tingling in the hands or feet, dry mouth, constipation, and changes in taste. These often improve as your body adjusts during the first few weeks on the starter dose.

Qsymia can raise your resting heart rate. In clinical monitoring, patients on the medication saw an average increase of about 3.6 beats per minute compared to placebo. Your prescriber may check your heart rate at follow-up visits, particularly if you have a history of heart disease.

A less obvious concern is metabolic acidosis, a condition where acid builds up in your blood. The topiramate component of Qsymia can lower bicarbonate levels, which is why bloodwork is repeated during treatment. Symptoms can be subtle: fatigue, loss of appetite, or faster breathing. If your lab results show persistently low bicarbonate, your dose may need to be reduced.

One specific drug interaction to know about: if you take any medication that works as a carbonic anhydrase inhibitor (some glaucoma eye drops fall into this category), combining it with Qsymia increases the risk of both metabolic acidosis and kidney stones. Make sure your prescriber knows about every medication you use, including eye drops.

How to Stop Safely

Don’t stop Qsymia abruptly, especially if you’re on the higher doses. The topiramate component is also used to treat seizures in other formulations, and stopping it suddenly can lower your seizure threshold. Your prescriber will taper you down, typically by dropping to a lower dose for at least a week or two before stopping completely. If you need to discontinue for any reason, including pregnancy, call your prescriber for a tapering plan rather than simply skipping doses.

Getting the Most From Treatment

Qsymia works through two mechanisms: phentermine reduces appetite, while topiramate (an extended-release form of a medication originally developed for seizures) appears to reduce food cravings and increase feelings of fullness. But the clinical trial results that showed 8 to 10% body weight loss at one year came from participants who also followed reduced-calorie diets. The medication makes it easier to eat less, but it doesn’t replace the need to change what and how much you eat.

Weight loss typically becomes noticeable within the first few months. The 12-week checkpoints built into the dosing schedule serve a practical purpose: if the medication isn’t producing meaningful results by then, continuing at the same dose is unlikely to help. Your prescriber will use those windows to decide whether to increase the dose, maintain it, or stop the medication entirely.